🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Solbinsiran inhibits hepatic #ANGPTL3 translation and results in significant reductions in all atherogenic lipoproteins in mixed dyslipidemia. The impact of this approach on CV outcomes remains to be determined. jacc.org/doi/10.1016/j.… #JACC Prof Kausik Ray FMedSci Giacomo Ruotolo

Following the #EASCongress2025, we’re pleased to share that Phase 2a and preclinical data from our MAR001 program have been published in The Lancet and eBioMedicine – The Lancet Discovery Science, respectively. A sincere thank you to the Marea team members, clinical trial investigators and patients who have

May 17th, the Hypertension World Day! As healtcare professionals, we have to care at our best the patients and show them the best example! Let's measure your blood pressure! SIIA International Atherosclerosis Society (IAS) European Atherosclerosis Society

🧬 Are very low Lipoprotein(a) levels a hidden metabolic risk? In our latest review in Current Opinion in Lipidology, we explore the paradoxical relationship between Lp(a), insulin resistance, and type 2 diabetes. 🔎 Key insights: 1⃣Elevated Lp(a) increases cardiovascular risk

🫶 #EASSoMe

Many patients (& colleagues) scared by high levels of Lp(a) ask me how to reduce CV risk while waiting for the development of specific drugs... Reduce LDL with statins, whose protective effect exceeds the negative effect of Lp(a) in the long term! International Atherosclerosis Society (IAS) European Atherosclerosis Society

🚨 Register now! We are pleased to launch a new series of Advanced Courses on Non-Classical Risk Factors for Cardiovascular Disease! 🧠 Learn about emerging drivers of CVD beyond the usual suspects: ✨ Chronic inflammation ✨ Gut microbiota ✨ Psychosocial stress ✨

🧬 EAS Advanced Course on Rare Lipid Disorders: Bridging Knowledge and Clinical Practice in Latin America Are you a clinician or healthcare professional in LatAm working in lipidology or cardiovascular care? Join our free online course to deepen your understanding of rare lipid

👉Curso European Atherosclerosis Society Dislipidemias Raras o poco frecuentes 🙌Imperdible actividad en español! 📆 11 Junio 16 hs. (ART) ☝️Actividad no arancelada 👨🏻‍⚕️🧑🏻‍⚕️Con la participación de un cuerpo docente de primer nivel Raul Santos Laura Schreier Rodrigo Alonso Karlezi juan Patricio

🌟 We’re thrilled to announce that one of EAS’s most impactful initiatives — the EAS Young Fellows Programme for Future Leaders — has been selected as a finalist in the International & European Association Success Awards in the category Best Young Member Initiative! 🏆 This

We are proud to announce that Professor Alexandros Tselepis has been named an Honorary Member of the European Atherosclerosis Society at the EAS Congress 2025 — a prestigious recognition of his outstanding contribution to the field. Warm congratulations and best wishes!

🎙️ New AtheroTalk episode out now! In this special live episode recorded at the #EASCongress2025, hosts Emiel Van der Vorst and Azin Kheirkhah sit down with two leading figures in cardiovascular research: 🌟 Prof. Judith Sluimer, recipient of the prestigious Vici grant (Dutch

🎓 Free Access to the EAS Certificate of Excellence in Lipidology – Apply by June 30! Are you a member of a national atherosclerosis society affiliated with EAS? Don’t miss this opportunity to join our comprehensive online course in clinical lipidology – for free! About the

Best of EAS 2025 – Singapore 1–2 August 2025 Join us for a new dynamic cardiology congress in Asia, where the most impactful highlights from the EAS Annual Congress in Glasgow will be brought to Singapore! 📍 Designed for healthcare professionals, researchers, and industry

The newly proposed clinical staging system represents a major step forward—enabling earlier identification and more proactive management of metabolic disorders. Professor Mansoor Husain, Co-Chair of the consensus panel on systemic metabolic disorders, reflects on the latest EAS

Invitation from Professor Pablo Corral Join us for the upcoming EAS Advanced Course on Rare Lipid Disorders: Bridging Knowledge and Clinical Practice in LatAm 🗓️ Date: 11 June 2025 🕓 Time: 16:00 ART (Argentina Time) 🌐 This course will be delivered in Spanish 👨‍⚕️ Tailored for

📢 New EAS Short Track Course: Novel Approaches to Lipid Lowering Therapies 🎓 This series aims to provide participants with a comprehensive understanding of the latest developments in lipid lowering therapies: • Pharmacological perspective by Prof Giuseppe Danilo Norata – covering key

🎓 From EAS Young Fellow to expert contributor! At EAS, we believe in nurturing the next generation of experts. That’s why participants in our Young Fellows Programme are regularly invited to take part as observers in our prestigious Consensus Paper initiatives—gaining firsthand

Great to be at ⁦National Lipid Association⁩ with ⁦Prof Kausik Ray FMedSci⁩ Great science with good friends! ⁦European Atherosclerosis Society⁩